PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsRiastap
Riastap
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
76 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HemorrhageD006470MP_0001914R5861379332
AfibrinogenemiaD000347—D68.2—42128
Wounds and injuriesD014947—T14.83611—8
Blood coagulation disordersD001778EFO_0009314D68.9111316
Hemostatic disordersD020141——111316
HemostasisD006487——121126
Postpartum hemorrhageD006473—O7211—214
ThrombosisD013927—————3—3
Soft tissue injuriesD017695————21—3
Disseminated intravascular coagulationD004211HP_0005521D65———112
Show 8 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Surgical blood lossD016063———14—38
Heart diseasesD006331EFO_0003777I51.9—21——3
Cardiovascular diseasesD002318HP_0001626——11——2
Liver diseasesD008107HP_0002910K70-K77——1—12
Breast neoplasmsD001943EFO_0003869C50——1——1
Postoperative hemorrhageD019106————1——1
Intraoperative complicationsD007431————1——1
Lung diseasesD008171HP_0002088J98.4——1——1
Kidney neoplasmsD007680EFO_0003865C64——1——1
Hemorrhagic shockD012771————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324—I25.1—2———2
Transfusion reactionD065227—D69.51—1——12
Heart valve diseasesD006349EFO_0009551I08—1———1
Multiple traumaD009104—T0711———1
Traumatic brain hemorrhageD020201——11———1
Postoperative complicationsD011183———1———1
Congenital heart defectsD006330HP_0001627Q24.9—1———1
Acute lung injuryD055371EFO_0004610——1———1
Lung injuryD055370—S27.30—1———1
Transfusion-related acute lung injuryD000073617—J95.84—1———1
Show 4 more
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C16————11
AdenomaD000236——————11
Stomach diseasesD013272——————11
Esophageal diseasesD004935EFO_0009544K22.9————11
LaparoscopyD010535——————11
Lymph node excisionD008197——————11
Cerebral ventricle neoplasmsD002551EFO_0007201—————11
Sinus floor augmentationD059546——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification—
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use